Tagrisso 80mg Tablet

Salt Composition: Osimertinib  
Manufacturer: ASTRAZENECA PHARMA INDIA LTD  
0 0 17
Out of Stock
   Check delivery options  
 
Share: 

About

Tagrisso 80mg Tablet contains the active ingredient Osimertinib, an antineoplastic medication classified as a protein kinase inhibitor. It is used to treat adults with non-small cell lung cancer (NSCLC) that shows specific mutations in the EGFR (epidermal growth factor receptor) gene, which indicate a likely response to this treatment.

Tagrisso may be prescribed after complete surgical removal of cancer as adjuvant therapy or as a first-line treatment for NSCLC that has spread to other parts of the body. It is also used in adults with certain types of advanced NSCLC who have not responded successfully to previous similar chemotherapy treatments. This medicine is not recommended for use in children or adolescents under 18 years of age.

Avoid taking Tagrisso 80mg Tablet if you are allergic to Osimertinib or any of its components. Before beginning treatment, inform your doctor if you have any existing kidney, heart, or eye conditions or a history of lung inflammation. Report any signs such as difficulty breathing, cough with fever, severe skin peeling, persistent fever, unusual bleeding or bruising, extreme fatigue, pale skin, or signs of infection.

 Uses 

  • Non-small cell lung cancer

Directions for use

This medicine should be administered by a doctor or nurse. Please do not attempt to self-administer it.


Side effects 
    

  • Muscle and joint pain
  • Nail changes
  • Dry skin
  • Tiredness
  • Cough
  • Inflamed and sore mouth 
  • Decreased heart function, irregular heartbeats
  • Breathing difficulty together with a cough or fever
  • Eye problems
  • Anemia
  • Skin lesions
  • Low WBC and platelets
  • Diarrhea, decreased appetite
  • Anemia
  • Rash

    
Safety Measures

Alcohol - The safety of consuming alcohol while taking Tagrisso 80mg Tablet is not well established. It is advisable to consult your doctor for personalized guidance.
Pregnancy - Tagrisso 80mg Tablet is not safe for use during pregnancy, as it may harm the developing fetus. Inform your doctor if you are pregnant, think you might be pregnant, or are planning to conceive. It is essential to use effective contraception during treatment and for at least 2 months after the final dose.
Breastfeeding - Breastfeeding is not advised while taking Tagrisso 80mg Tablet, as the medication may pass into breast milk in small amounts and could potentially harm your baby.
Liver - Tagrisso 80mg Tablet can be safely used in patients with liver conditions, and dose adjustments are generally not required in cases of mild, moderate, or severe liver impairment. However, inform your physician if you have any liver-related issues before starting the treatment.
Kidney - The effects of Tagrisso 80mg Tablet on the kidneys are not well established. Consult your doctor if you have any kidney-related concerns before starting the treatment.

  Disclaimer

Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient reilationshp.

Shipping Cost
Shop Location Assam, India

No comments found for this product. Be the first to comment!